AI to Design All Drugs in Future, Says Isomorphic Labs President

• Isomorphic Labs, a Google DeepMind spinoff, aims to use AI to design all future drugs.
• President Max Jaderberg believes AI will design all medicines in the future.
• Jaderberg suggests this transition could happen within five years.
• Isomorphic Labs is based in London's AI hub and is led by AI pioneer Demis Hassabis.
• The company is focused on developing cancer-beating drugs.